Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Carcinoma in Situ and CHEK2[original query] |
---|
Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Jul 28 (7): 1162-1168. Petridis Christos, Arora Iteeka, Shah Vandna, Moss Charlotte L, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor |
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50?years. Breast cancer research : BCR 2019 May 21 (1): 58. Petridis Christos, Arora Iteeka, Shah Vandna, Megalios Anargyros, Moss Charlotte, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor |
High risk of breast cancer in women with biallelic pathogenic variants in CHEK2. Breast cancer research and treatment 2020 1 180 (2): 503-509. Rainville Irene, Hatcher Shanell, Rosenthal Eric, Larson Katie, Bernhisel Ryan, Meek Stephanie, Gorringe Heidi, Mundt Erin, Manley Sus |
Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer. Genetics in medicine : official journal of the American College of Medical Genetics 2021 Jun . Woodward Emma R, van Veen Elke M, Forde Claire, Harkness Elaine F, Byers Helen J, Ellingford Jamie M, Burghel George J, Schlech Helene, Bowers Naomi L, Wallace Andrew J, Howell Sacha J, Howell Anthony, Lalloo Fiona, Newman William G, Smith Miriam J, Gareth Evans |
High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer. Journal of medical genetics 2021 3 59 (2): 115-121. Evans D Gareth, van Veen Elke Maria, Byers Helen J, Evans Sarah J, Burghel George J, Woodward Emma Roisin, Harkness Elaine F, Eccles Diana M, Greville-Haygate Stephanie L, Ellingford Jamie M, Bowers Naomi L, Pereira Marta, Wallace Andrew J, Howell Sasha J, Howell Anthony, Lalloo Fiona, Newman William G, Smith Miriam Ja |
Spectrum of histopathologic findings in risk-reducing bilateral prophylactic mastectomy in patients with and without BRCA mutations. Human pathology 2023 11 . Baris Boyraz, Amy |
Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants. Cancer genetics 2023 10 278-279 84-90. Erin Mundt, Brent Mabey, Irene Rainville, Charite Ricker, Nanda Singh, Anna Gardiner, Susan Manley, Thomas Slav |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source: